Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since the Response cited some Latin, figured I would send some Latin out to DECN in return ....
"Stercore quod Stercore" ....
"Sh_t is Sh_t"
Was Berman projecting with this line in the Response?
'falsus in uno, falsus in omnibus’ – false in one thing, false in everything
Sounds familiar after being in this stock for 4 Plus years!
Chief Excuse Officer!
Poor, Poor Berman .... sooooo misunderstood! ROTF!
ONE "DECN Mystery" solved - April 7, 2020 DECN Press Release -
DECN Receives Pre-EUA Acknowledgement Letter And Product Serial Number From U.S. FDA For GenViro!(TM) Covid-19 Screening Kit For Professional Use
Per a copy of the FDA Letter in DECN's Response in Exhibit C, "This submission has been assigned the unique document control number below."
Below in the FDA letter is DOCUMENT CONTROL NUMBER PEUA200323 .... Product Serial Number sounds more sexy, right Berman and legions?
This number is not called a Product Serial Number as the DECN Press Release asserts.
I am coming to this board late today so I apologize if someone has already pointed out this DECN defect. For all those posters who called at DECN for this "product serial claim," no surprise BUT you were right and not even the DECN virtual IR, friend of Berman did not offer a correction.
One of many DEFECTS in the DECN Response, IMO!
Loan, got it ....thanks... makes sense!
Like a submarine with screen doors!
CV, very thorough yet concise and pragmatic post ..... I hope you did not get caught up in that Shareholder Letter drama!
What happened to the 100K kits to Canada and 100K kits to the EU in May 2020?
To DECN ShareHolders Past or Present who welcome the SEC's efforts to help protect investors .... STOP doing the homework for these "ill-guided" ones....don't let them fish for defenses from you. I am sure the SEC and any other involved entities, process will work!
As far as the SEC not posting the DECN 8K Creative Writing exercise due June 3 .... IF both parties agreed to an extension, that could be the reason why it has not been posted yet.
REMEMBER, IMO, DECN will delay this as best they can .... IMO, a speedy result wil not be beneficial to DECN. ALSO, REMEMBER this exercise is JUST related to the suspension ALTHOUGH the charges of BOTH DECN and the Shareholders' Letter against the SEC process and integrity of a 25 year SEC staffer is, IMO, typical Hockey Buddy or the virtual DECN Court Jester or nasty response to a shareholder asking questions related to their investment BUT puts the CEO on the spot for accountability just pure bullying and cyberbullying at that are, IMO, POS annd you gotta flush
twice!
People who signed the Shareholder Letter put a lot of faith into Matthew and the members of the "ill-guided" cabal BUT then again the Pied Pipers of DECN, IMO, like blind "followers" and gulible mice!
How's Kenny Bass making out with those FOIA Requests?
FOIA log for the April 2020:
Request ID 20-01383-FOIA
Requester Name Bass, Kenneth L.
Organization -
Requester Category Other
Request Description Consumer complaints from January 1, 2016 to
April 28, 2020 for Decision Diagnostics
Received Date 4/28/2020
Request Status Referral Request
Closed Date -
Final Disposition -
------------------------------------
Request ID 20-01384-FOIA
Requester Name Bass, Kenneth L.
Organization -
Requester Category Other
Request Description BD Applications and Amendments, from January 1,
2016 to April 28, 2020 for Decision Diagnostics
Corp
Received Date 4/28/2020
Request Status Closed
Closed Date 5/7/2020
Final Disposition Other Reasons
-------------------------------------
Johnny C, Rawman, Roofus and IPwatcher had links for IHUB messages posted in the Shareholder Letter in regards to the "alleged hack"
I guess Berman didn't have any IT counsel for that "creation" .... I think that the "Devil made me do it" would have been a better excuse!
ROTF!
Excellent find .... can think of many "investors" who may qualify for similar actions, IMO!
Those idiot shareholders couldn't wait to contribute.
That's not a nice way to treat and label your co-signators!
SAD!
Shareholders sent the letter last week. Berman had nothing to do with the letter, but I did, and so did almost 60 other shareholders, most important word here, shareholders.
This is a keeper! No need to search for the DECN, Delusion, Distracting cabal and its "leader" PLUS the hacked file saga PLUS so much more!
KNOCK! KNOCK!
Is it possible with this game of Clue that PlutoniumImplosion is Col Mustard and he used the computer to facilitate this, IMO, hoax?
Knock, Knock!
My slide (downloaded on 3/14) pre-dates the 3/30 one and has the Advantage Meter cited on page 12 versus the Precision Meter on the 3/30 post page 12.
Additionally, the link I used that was on the PharmaTech website was:
http://www.pharmatechsolutions.co/assets/inserts/20200313_GenViro!_PP.pdf
Note the date in the file name above (20200313) as compared to the file name (20200318) in the link of the 3/30 post.
KNOCK, KNOCK!
If you are going to have cyber criminals at all, the thoughtful, helpful kind are the best, don't you think!
Knock, Knock as they say ..... what's that line about knowingly providing false statements?
Bits and Bytes!
Angel2020, did you realize your link lists 31 people by name associated with this PDF?
IP, here is the link from my History file that I downloaded on March 14th -
http://www.pharmatechsolutions.co/assets/inserts/20200313_GenViro!_PP.pdf
N.B. The file name contains, in part, 20200313 and on page 12 contains,
?Product: GenViro! COVID-19 Screen
?PharmaTechSolutions sensors for screening the Coronavirus
?FDA cleared for use with GenUltimate! Avantage! Meter
?PharmaTechSolutions is a wholly owned subsidiary of Decision Diagnostics Corp. (OTCBB:DECN)
?Types of Products: Home diagnostic and testing supplies
?Primary Customer: People concerned about the Coronavirus and consumers who have GenUltimate! Avantage! Meters.
?Typical Usage: 1 test to screen for COVID-19
Doesn't it seem "DECN Strange" that the post cited in the ShareHolder Letter is from 3/30 and the link is
http://www.pharmatechsolutions.co/assets/inserts/20200318_GenViro!_PP.pdf .... it has, in part, a file name of 20200318 AND says,
PAGE 12 FDA CLEARED
Product: GenViro! COVID-19 Screen
? PharmaTech Solutions sensors for screening the Coronavirus
? FDA cleared for use with GenViro! Precision Meter
? PharmaTech Solutions is a wholly owned subsidiary of Decision Diagnostics
Corp. (OTCBB:DECN)
? Types of Products: Home diagnostic and testing supplies
? Primary Customer: People concerned about the Coronavirus and consumers
who have GenViro! Precision Meters.
? Typical Usage: 1 test to screen for COVID-19
P
I GUESS, NOT ONLY did the "cybercriminals" hack DECN BUT corrected the linked file 20200313 from the ADVANTAGE METER to the linked file 20200318 PRECISION METER.
GenViro! Swift ..... Which ONE is it, DECN/PharmaTech Solutions? Still in PRODUCTION or still in DEVELOPMENT?
"Not yet available for sale, still in production."
http://www.pharmatechsolutions.co/products.html
OR,
"This product is currently still in development and not available for sale."
http://www.pharmatechsolutions.co/genviro.html
OR, Let's use Quantum Physics .... BOTH are true for DECN!
AT LEAST they got the "NOT AVAILABLE for SALE" right this time!!!! ROTF!
Another HACK JOB?
-.-. .... .. . ..-. / . -..- -.-. ..- ... . / --- ..-. ..-. .. -.-. . .-. / -... . .-. -- .- -. / .- - / .-.. .- .-. --. .
Based on the "god" complex issues and the recent DECN Court Jester writing that this is a fight between "good and evil," I'll go in at the brief coming in at 7666 words!
GO SEC!
Already on CVS and Walmart store shelves ....
CVS HEALTH CORP to Distribute New Diabetic Nutrition Beverage From Glucose Health, Inc.
5:30 am ET June 3, 2020 (PR Newswire)
Glucose Health, Inc. (OTC: GLUC) today confirmed that CVS HEALTH CORP - the nation's largest pharmacy retailer - has agreed to distribute the Company's innovative beverage for the adult-diabetic nutrition retail category, GLUCODOWN(R).
Murray Fleming, CEO of Glucose Health, Inc., stated, "CVS is embarking on a significant corporate expansion of diabetic care at many of its pharmacies nationwide and we are very pleased GLUCODOWN(R) has been included given the important role nutrition can play in this initiative."
Many clinical studies underpin the efficacy of the principal nutritional ingredient in GLUCODOWN(R). Clinical data generated from this research was submitted to the Food & Drug Administration (FDA) by the ingredient manufacturer, resulting last year in favorable revision to FDA regulations and industry guidance with regard to the labeling of products utilizing the ingredient, including GLUCODOWN(R).
CVS is a leader among pharmacy retailers in mandating independent third-party testing using the ANSI 173 standard - the only American National Standard for testing and certifying dietary supplements, maintained by NSF International. Random samples of GLUCODOWN(R) were provided to NSF International and the successful test results were released simultaneously to CVS and Glucose Health, Inc., on May 5, 2020.
About Glucose Health, Inc. (OTC: GLUC)
GLUCODOWN(R) is formulated to serve consumers which comprise the diabetic/adult nutrition retail category. More than 100 million Americans are estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.[1] Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.
For more GLUC news visit www.glucosehealthinc.com.
1. National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services.
Here is the status of a "functional device" as of April 13, 2020:
In addition, as of April 13, 2020, Berman, who alone drafted the press releases on behalf of DECN, stated or suggested in interviews with staff that he:
• knew that the company had no COVID-19 test kits;
• had not seen any of DECN’s prototype COVID-19 test kits;
• had no idea how many test kits DECN could produce;
• knew that the COVID-19 test kits would require component parts that were different from DECN’s current diabetes products, which the company did not yet have and would need before any sales could be made;
Have those 100,000 kits been delivered to Europe yet? ONLY 3 more days to go .... Have the 100,000 kits for Europe even been manufactured yet?
March 16, 2020 - DECN Press Release, in part .... Further, we will engage in the EU with administrators of the ISO standard CE regulatory process this week. Only two diagnostic methodologies have been approved in the EU, none with the cost effectiveness or promise of GenViro! Our plan is designed to bring at least 100,000 of our kits to market in the USA and Canada, and another 100,000 in Europe, during the month of May 2020.
FROM the SEC Information Before the Commission, in part:
In addition, as of April 13, 2020, Berman, who alone drafted the press releases on behalf of DECN, stated or suggested in interviews with staff that he:
• knew that the company had no COVID-19 test kits;
• had not seen any of DECN’s prototype COVID-19 test kits;
• had no idea how many test kits DECN could produce;
• knew that the COVID-19 test kits would require component parts that were different from DECN’s current diabetes products, which the company did not yet have and would need before any sales could be made;
From April 13, 2020 to May 31, 2020 .....100,000 kits to Europe? Seems a little aggressive timeline and that does not even deal with the 100,000 to the USA and Canada?
WOW!
Where in the SEC's Information Before the Commission did it cite use of the "alleged hacked" DECN document in its Information and/or Suspension determination?
SHOW PROOF!
I see only mention of the DECN website "About Us" content, DECN Press Releases authored solely by Berman, interviews of Berman by SEC staff, the Berman/Access HealthNet (Kalmus, et al. v. Wertz et al. No. SACV-96-1250-GLT), and other publicly available information.
ONLY four days left in May 2020, is DECN going to achieve its statement below in regards to the EU with administrators of the ISO standard CE regulatory process AND 100,000 kits to Europe during May?
IF NO, what is the DECN excuse this time?
DECN Press Release .... (March 16, 2020) -- Further, we will engage in the EU with administrators of the ISO standard CE regulatory process this week. Only two diagnostic methodologies have been approved in the EU, none with the cost effectiveness or promise of GenViro! Our plan is designed to bring at least 100,000 of our kits to market in the USA and Canada, and another 100,000 in Europe, during the month of May 2020.
"others" "others" "others"
Classic DECN, IMO, It Is Always Someone Elses Fault!
Chief Excuse Officer
SAD!
Remember with DECN, IMO, It Is Always Someone Elses Fault!
So KB wasn t so squeaky clean...very interesting
Maybe Berman was "hacked" - Too funny!
YET is the key word here, Johnny .....
Maybe the SEC will make referals to other regulatory and/or investigative agencies .... IRS, FBI, etc.
Where is proof of the hacking? Where are the criminal complaints of the "hacking event"?
Pluto referred to the hacking as low level so between GoDaddy, HostGator, the "DECN/PharmaTech Solutions IT Dept." (ROTF), CA Cyberlaw as well as Federal Cyber law, maybe even the FTC and/or FCC there should be no problem for DECN to cite proof of the "alleged" hacking in its response to the SEC's information.
The saga continues ....
What does a publicist or lobbyist do?
Did anyone putting the amended 550 together verify the statements made? Did they look at the April 23, 2020 Press Release?
FROM DECN Amended 550, "25. DECN has never hired, retained, and has not had any understanding with any individual or entity to promote or tout the Company or its business to the public."
FROM DECN Press Release April 23, 2020, in part ...
On April 13, 2020 the company engaged a publicist and a lobbyist. The publicist has engaged three media outlets, who have shown great interest in the story of GenViro! Swift and want to interview DECN CEO Berman. One has already run a short introductory description of the product and is preparing a longer, more involved segment and has already accepted a number of visuals from us for the report. It is interesting to note that the media outlets are well versed in Covid-19 testing methods and are excited about GenViro! Swift not just for its promise but also because it is so different and so much faster to report than other methods currently available.
In addition, the company's lobbyist has engaged several influential members of Congress who have spoken at length with the company and its representatives. The Congressmen have agreed to carry the ball on behalf of the company, beginning with direct communication with the Pence Covid-19 Task Force. This process began on April 20.
DECN Press Release March 16, 2020, in part ....
"Our plan is designed to bring at least 100,000 of our kits to market in the USA and Canada, and another 100,000 in Europe, during the month of May 2020."
It is May 26th today, will DECN make at least one of these statements a reality?
USA and Canada ....at LEAST 100,000 kits to market in the USA and Canada
AND/OR
another 100,000 kits to market in EUROPE
4 more days to go - Such a feat would be Press Release worthy by any company, IF ACHIEVED!
So DECN, where are the kits or did an "alleged hacker" change this DECN Press Release?
DECN March 3, 2020 Press Release ...
"The TBG Precise meter is now complete and available for US license to our strategic partner."
What is the status of this statement made by DECN?
Who is the "strategic partner?"
For years we have been taunted by the DECN court jester to call the SEC, FBI, police, state police, Marines, Navy, etc and on and on, I guess someone or somebodies did or a regulatory or criminal agency finally did it on their own - Guess the DECN court jester should take comfort in knowing someone or something took his advice? Berman, shareholders past and present, the Nobel Prize Committee, the world should THANK or BLAME the DECN court jester for the suggestions!
Great Job!
SEC will provide INFORMATION ONLY today to DECN/Counsel, briefs will follow on dates listed below ....
By May 20, 2020, the Division of Enforcement shall file all the information that was before the Commission at the time of the Trading Suspension Order’s issuance.
By June 3, 2020, DECN shall file an opening brief, which is not to exceed 8,000 words.
By June 17, 2020, the Division shall file an answering brief, which is not to exceed 8,000 words.
By July 1, 2020, DECN may file an optional reply brief, which is not to exceed 3,000 words.
This matter relates to the 550 filed by DECN. The SEC and possibly other agenies may be still looking into DECN for further actions.
Better questions, Johnny ...... What is the status of the GenViro patent? What names are on the patent? Has the patent been assigned to anyone? If yes, what are the terms?
Decision Diagnostics http://www.decisiondiagnostics.co/
PharmaTech Solutions http://pharmatechsolutions.co/
Full Circle Diabetes http://fullcirclediabetes.com/
NONE of the above websites use HTTPS .....
Hypertext Transfer Protocol Secure (HTTPS) is a variant of the standard web transfer protocol (HTTP) that adds a layer of security on the data in transit through a secure socket layer (SSL) or transport layer security (TLS) protocol connection.
This is a BASIC Security Measure....https
Full Circle Diabetes at CHECKOUT states, "All data is transmitted encrypted via a secure TLS connection."
Transport Layer Security (TLS) is a protocol that provides authentication, privacy, and data integrity between two communicating computer applications. It's the most widely-deployed security protocol used today and is used for web browsers and other applications that require data to be securely exchanged over a network, such as web browsing sessions, file transfers, VPN connections, remote desktop sessions, and voice over IP (VoIP).
The "IT person" needs some shaking up .... does Berman wear that hat as well as sole Board Member and CEO .....seems he is involved with just about EVERYTHING at DECN .... We'll see if he is held equally ACCOUNTABLE for EVERTHING at DECN.
Pleas re-post that 2016 post - If about hacking would be very interesting - Thanks!
Accordingly, IT IS ORDERED that the parties file submissions as follows:
By May 20, 2020, the Division of Enforcement shall file all the information that was before the Commission at the time of the Trading Suspension Order’s issuance.6
6 See 15 U.S.C. § 78l(k)(5). The Division need not disclose privileged legal analysis or sensitive information about the staff’s investigative methods.
By June 3, 2020, DECN shall file an opening brief, which is not to exceed 8,000 words.
By June 17, 2020, the Division shall file an answering brief, which is not to exceed 8,000 words.
By July 1, 2020, DECN may file an optional reply brief, which is not to exceed 3,000 words.
When are you going to become the next CEO and Chairman of DECN?
SHORT ANSWER: NEVER! I would not assume the liability created under the tenure of the DECN Chief Excuse Officer.
Just what the company needs, a patent expert.
IMO, the company needs a successful Law Firm.
Now answer my questions:
Has the patent for GenViro! been submitted?
IF NOT, WHY NOT?
OR, do we have to wait until Aug 15th?
Will Colombo solve the mystery of the ALLEGED computer hack by then? ROTF!
As usual, no answers to simple questions ....
Has the patent for GenViro! been filed yet?
IF NOT, WHY NOT?
Has the patent for GenViro! been filed yet?
Per the DECN 1Q 2020 Report, "The company has retained patent counsel to file three patents (in 3Q 2019) for our GenUltimate! TBG and GenPrecis meters and test strips, and for our newest adaptation, our two GenViro! Covid-19 test kits.
IF NOT, WHY NOT? Could it be because GenViro! is neither "useful" and/nor "operative"? Is GenViro! just "a mere idea or suggestion" that would not qualify it for a patent?
What can be patented?
https://www.uspto.gov/patents-getting-started/general-information-concerning-patents#heading-4
The patent law specifies that the subject matter must be “useful.” The term “useful” in this connection refers to the condition that the subject matter has a useful purpose and also includes operativeness, that is, a machine which will not operate to perform the intended purpose would not be called useful, and therefore would not be granted a patent.
-------
A patent cannot be obtained upon a mere idea or suggestion. The patent is granted upon the new machine, manufacture, etc., as has been said, and not upon the idea or suggestion of the new machine. A complete description of the actual machine or other subject matter for which a patent is sought is required.